Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-13-013355)

Filing Details

Accession Number:: 0001225208-13-013355
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-28 16:37:08
Reporting Period:: 2013-05-28

Filing Date:: 2013-05-28
Accepted Time:: 2013-05-28 16:37:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
14272	Bristol Myers Squibb Co	BMY	Pharmaceutical Preparations (2834)	220790350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1480250	A Charles Bancroft	Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154	Evp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	Disposition	2013-05-28	25,000	$48.68	94,015	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $48.65 to $48.76, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.